Discover All Events

Bronchiectasis continues to gain increasing attention within the global respiratory healthcare community due to growing awareness, improved diagnosis methods, and advances in treatment strategies. Research collaborations, patient-focused initiatives, and international knowledge-sharing platforms are essential for improving outcomes for people living with bronchiectasis. The Bronchiectasis Research Forum 2026 is designed as a specialist healthcare conference bringing together clinicians, researchers, scientists, patient representatives, and healthcare organisations to discuss the latest developments in bronchiectasis research and management. The event provides a dedicated platform for professionals to exchange knowledge, explore new research findings, and strengthen collaboration across the respiratory healthcare community. EMBARC has established itself as an important international network supporting bronchiectasis research, clinical improvement, and collaboration between healthcare professionals across Europe. Purpose of the Event The primary goal of the Bronchiectasis Research Forum 2026 is to accelerate improvements in bronchiectasis understanding, diagnosis, treatment, and long-term patient support. The conference focuses on bringing together different areas of expertise, including: Clinical respiratory medicine Medical research Patient care strategies Healthcare innovation Clinical trial development Digital health solutions By creating opportunities for discussion and collaboration, the event supports the development of better approaches for managing bronchiectasis. Latest Advances in Bronchiectasis Research Scientific research continues to transform how bronchiectasis is diagnosed and treated. The conference will explore important developments in areas such as disease monitoring, personalised treatment approaches, infection management, and emerging therapies. Researchers will share insights into ongoing studies and explain how new evidence can influence future clinical practices. Key research topics may include: Understanding disease progression Improving early diagnosis Managing chronic respiratory infections Reducing exacerbations Developing new therapies Improving quality of life for patients The event creates an opportunity for attendees to understand how research discoveries can translate into practical healthcare improvements. Expert Presentations and Knowledge Sharing The conference programme will feature presentations from specialists working in respiratory medicine and clinical research. Experts will discuss challenges faced by healthcare professionals and highlight innovative solutions that can improve patient outcomes. Sessions will focus on: Advances in bronchiectasis treatment Clinical guideline updates Research findings Patient-centred healthcare models Future directions in respiratory medicine These sessions will provide valuable learning opportunities for professionals seeking to expand their knowledge of bronchiectasis. Collaboration Between Healthcare Professionals Collaboration is essential for improving respiratory healthcare outcomes. The event encourages professionals from different backgrounds to connect, share experiences, and develop new partnerships. Participants will include: Hospital specialists Respiratory consultants Researchers Universities Healthcare organisations Patient representatives By encouraging open discussions, the conference helps build stronger networks dedicated to advancing bronchiectasis care. Patient-Centred Approach Modern healthcare increasingly focuses on involving patients in research and treatment decisions. The event recognises the importance of understanding patient experiences and ensuring that healthcare improvements address real-world challenges. Discussions will explore: Patient quality of life Managing daily symptoms Improving communication between patients and clinicians Supporting self-management strategies Patient representatives play an important role in ensuring research priorities reflect the needs of people living with bronchiectasis. Exploring Future Treatments Medical research continues to investigate new approaches for bronchiectasis management. The conference will highlight future opportunities including: Innovative medicines Advanced diagnostic technologies Clinical trial developments Personalised healthcare approaches Digital monitoring solutions These developments have the potential to improve disease management and reduce the impact of bronchiectasis on patients. EMBARC has supported international research efforts aimed at improving understanding and treatment options for bronchiectasis. Networking Opportunities Networking is a major benefit of attending the Bronchiectasis Research Forum 2026. Delegates will have opportunities to: Meet international experts Exchange research ideas Build professional relationships Discuss future collaborations Connect with healthcare organisations These interactions encourage partnerships that can contribute to future research projects and healthcare improvements. Who Should Attend? The event is suitable for: Respiratory specialists Pulmonologists Clinical researchers Medical professionals Academic institutions Healthcare organisations Patient advocacy representatives Pharmaceutical and biotechnology professionals Anyone involved in bronchiectasis research, treatment, or patient support can benefit from attending this conference. Benefits of Participation Attendees will gain: Updated knowledge about bronchiectasis research. Insights from respiratory experts. Opportunities to collaborate with specialists. Awareness of emerging treatments. Access to healthcare networking opportunities. Understanding of future research priorities. The event supports continuous professional development while strengthening the global respiratory healthcare community. Wrapping Up The Bronchiectasis Research Forum 2026 represents an opportunity for healthcare professionals, researchers, and patient advocates to collaborate on improving bronchiectasis care. Through expert presentations, research discussions, and networking opportunities, the conference supports innovation and knowledge exchange within respiratory healthcare. As research continues to advance, collaboration between clinicians, scientists, and patients remains essential for developing better treatments and improving quality of life for people affected by bronchiectasis.

The Wiley's Finest Omega-3 & Nutrition Expo 2026 serves as the UK's premier gathering for health practitioners, retail buyers, dietary researchers, and holistic wellness advocates. Hosted in Blackpool—the home of Wiley's Finest UK headquarters—this comprehensive three-day trade exhibition highlights the critical role of sustainable marine lipid chemistry, MSC-certified eco-labeling, and advanced bioavailability in modern nutritional supplementation. Attendees will explore how clean-label extraction techniques transform wild-caught Alaskan pollock into ultra-pure, high-potency Omega-3 concentrates designed to meet diverse human health requirements. Unveiling Breakthrough Concentrates and Formulations At the core of this year’s expo is the unveiling of Wiley's Finest updated seasonal line of peak-concentration liquids, softgels, and plant-powered nutrition options. Participants will gain direct access to interactive exhibit displays featuring Peak EPA, Prenatal DHA, CatchFree Omega, and targeted multi-benefit formulas infused with Vitamins D3 and K2. Every product presented emphasizes traceably caught, single-species wild Alaska pollock, purified using state-of-the-art molecular distillation. Retail stockists and health buyers will receive tailored product guides detailing how these concentrated formulas provide superior EPA and DHA content per dosage compared to standard fish oils. Clinical Research and Sustainable Marine Sourcing Beyond product displays, the expo features an extensive educational conference agenda. Renowned lipid scientists, marine conservationists, and registered dietitians will host keynote lectures addressing the growing clinical demand for high-concentration Omega-3 fatty acids. Key topics will cover cardiovascular protection, cognitive performance, ocular health, and prenatal developmental support. Furthermore, dedicated sustainability panels will detail Wiley's Finest strict adherence to Marine Stewardship Council (MSC) guidelines, illustrating how responsible fisheries management protects ocean ecosystems while guaranteeing supply chain integrity. Hands-On Workshops and Merchandising Masterclasses Designed to equip retail partners with practical tools for business expansion, the expo includes hands-on technical workshops and marketing seminars. Attendees can visit the interactive Sensory Tasting Lounge to sample natural taste formulations that overcome traditional fish oil aftertaste issues. Additionally, retail masterclasses will share digital marketing compliance strategies, point-of-sale display layouts, and consumer education techniques to help independent health food stores and pharmacies effectively communicate the value of premium, SQF-certified dietary supplements to their local communities. B2B Networking and Strategic Commercial Partnerships Networking is a central pillar of the Blackpool showcase. The event offers pre-scheduled B2B matchmaking lounges where health store owners, wholesale buyers, and pharmacy procurement managers can speak directly with the Wiley's Finest UK executive leadership team. Whether negotiating bulk distribution terms, setting up localized retail marketing support, or exploring professional practitioner lines, delegates will find an open, collaborative atmosphere geared towards mutual commercial growth and long-term industry partnership. Join Us in Blackpool for a Healthier Tomorrow Set in the iconic Blackpool Winter Gardens, this event blends high-level scientific dialogue with practical business solutions. Health industry leaders, retail decision-makers, and dietary professionals are encouraged to secure their registration early to gain access to exclusive trade pricing, sample kits, and direct participation in all technical seminars. Step into the future of clean, sustainable, high-potency nutritional science with Wiley's Finest UK this September.

The "Section 12 Induction" is a cornerstone of the Andrew Sims Centre’s educational calendar, providing the foundational training required for doctors seeking their first approval under the Mental Health Act. This two-day course is essential for psychiatrists and other eligible medical practitioners who wish to gain the authority to provide medical recommendations for the detention of patients. The curriculum is designed to be comprehensive and immersive. Day one focuses on the legal framework, defining the specific criteria for Sections 2, 3, and 4 of the Act. Day two moves into the practicalities of the role, including the nuances of the "nearest relative," the importance of the AMHP (Approved Mental Health Professional) partnership, and the human rights implications of depriving someone of their liberty. Through a series of lectures, mock assessments, and small-group discussions, participants will learn how to navigate the complex social and legal landscape of mental health crises. Attending both days is a strict requirement for receiving the certificate of completion, which is recognized by all four approval panels in England. This course provides 12 CPD points and remains one of the most respected inductions in the UK.

Adult ADHD has seen a significant rise in diagnostic rates and public awareness, yet clinical services often struggle to keep pace with demand. This one-day course, "ADHD in Adulthood," provides an up-to-date, clinically relevant overview of the disorder, focusing on the unique challenges presented by adult populations. The Andrew Sims Centre has curated this session to bridge the gap between childhood neurodevelopmental understanding and adult psychiatric practice. The morning sessions focus on the neurobiology of ADHD and the diagnostic process, including the use of validated screening tools and the importance of developmental history. The afternoon shifts toward management, covering both pharmacological treatments and non-pharmacological interventions such as CBT and coaching. A significant portion of the day is dedicated to comorbidities—addressing how ADHD frequently masks or co-exists with anxiety, depression, and substance misuse. Attendees will leave with a clear diagnostic framework and a modernized approach to treatment that emphasizes functional outcomes for patients. This course is an essential update for any clinician working in adult mental health, offering a space to discuss the complexities of high-functioning adults and late-life diagnoses.

Ensuring that mental health professionals remain current with the shifting landscape of legislation is the primary goal of the "Section 12 Refresher Course." This intensive one-day session is specifically designed for doctors who are already Section 12 approved and need to renew their status. Under the Andrew Sims Centre’s expert guidance, participants will review the latest legal updates, recent case law, and changes to the Mental Health Act Code of Practice that have occurred since their last induction or refresher. The course moves beyond mere theory, focusing on the practical application of Section 12 powers in crisis situations. Special attention is given to the quality of medical recommendations and the importance of clear, legally defensible documentation. Facilitators will lead discussions on the interface between the Mental Health Act and the Mental Capacity Act, as well as the nuances of assessing patients from diverse cultural backgrounds. As one of the premier providers of Mental Health Law training in the UK, the Andrew Sims Centre ensures that this refresher is both academically rigorous and clinically relevant, providing doctors with the 6 CPD points necessary for their re-approval application.

The Andrew Sims Centre is proud to present the "Approved Clinician Induction," a high-stakes two-day training event designed for senior mental health professionals seeking statutory approval. This course is specifically accredited by the North of England Approval Panel (NEAP) and serves as a mandatory component for practitioners wishing to take on the role of an Approved Clinician (AC) under the Mental Health Act. Over the course of two days, delegates will be immersed in the legalities, ethical dilemmas, and clinical responsibilities inherent in the AC role. The training is delivered by a multi-professional team of legal experts and experienced clinicians, ensuring a balanced perspective between "the letter of the law" and "clinical reality." Topics include the criteria for detention, the role of the Responsible Clinician, and navigating Mental Health Tribunals. The Andrew Sims Centre has a long-standing reputation for excellence in Mental Health Law training, and this induction is curated to ensure that every participant leaves with the confidence and competence required to fulfill these significant statutory duties. Success in this course provides 12 CPD points and is a recognized proof of completion for approval panels across England.

This comprehensive full-day seminar, titled "Potential Severe Adverse Effects of Psychotropic Medication (Part Two)," is a flagship offering from the Andrew Sims Centre’s clinical update series. While the primary benefits of psychotropic interventions in mental health are well-documented, this session dives deep into the "shadow side" of pharmacology. The curriculum focuses on identifying, managing, and mitigating long-term or permanent serious adverse effects that can significantly impact patient quality of life. The course is structured to provide clinicians with the latest evidence-based research regarding metabolic syndromes, tardive dyskinesia, and rare but life-threatening reactions like Neuroleptic Malignant Syndrome. Attendees will engage in interactive case study reviews, allowing them to apply diagnostic criteria to real-world scenarios. The session also covers the ethical implications of prescribing, emphasizing the importance of informed consent and the ongoing monitoring of patients on long-term medication regimens. By the end of the day, delegates will have a robust framework for assessing risk-benefit ratios in complex psychiatric cases. This event is vital for those looking to enhance patient safety and clinical excellence within their practice.